Chart Industries Drew a New $27 Million Bet Amid Record Orders and a $210 Per Share Buyout Deal

London-based Decagon Asset Management initiated a new 13Q position in Chart Industries (GTLS), purchasing 137,732 shares worth $27.57 million (≈13.92% of the fund's reportable U.S. equity) as of Sept. 30, making it the fund's second-largest holding. Chart trades at $205.96 with a $9.26 billion market cap, reported TTM revenue of $4.29 billion and net income of $66.7 million; Q3 orders were $1.68 billion (+44% YoY) and backlog hit a record $6.05 billion, while adjusted operating income and EBITDA were $251.5 million and $277.1 million (~25% margin). The filing and the Baker Hughes acquisition (implying a $210/share cash outcome if closed) underscore institutional interest in Chart’s energy/industrial equipment exposure and strong backlog-driven earnings profile, though the timing of the fund’s purchases relative to the M&A announcement is unclear.

Analysis

Market structure: The Baker Hughes (BKR) bid + Decagon's new ~13.9% 13F stake in Chart (GTLS) accelerates consolidation in cryogenic/LNG/hydrogen equipment, handing GTLS and integrated energy-service providers near-term pricing power given Chart's $6.05B backlog (+44% y/y) and adjusted EBITDA ~25% of revenue. Winners include GTLS, aftermarket service providers and EPC contractors executing large LNG/H2 projects; smaller niche OEMs and low-scale fabricators risk margin pressure and lost RFPs. Expect longer lead times, higher bid win rates and above-normal pricing for cryogenic capacity for 6–24 months.

Risk assessment: Tail risks — deal collapse, CFIUS/antitrust intervention, or execution bottlenecks — could cause a 10–25% downside quickly; conversely successful close + synergy delivery lifts to $210 cash floor then higher if growth sustains. Immediate window (days) is dominated by deal headlines and volatility; short term (weeks–months) by Q4 order conversion and earnings; long term (quarters–years) by hydrogen/LNG capex cycles and backlog conversion. Hidden dependency: Chart’s performance is levered to BKR’s ability to finance/integrate and to commodity cycles (LNG pricing, steel supply) that affect margins.

Trade implications: Direct: tactical long GTLS exposure sized 1–3% of portfolio, targeting $210 near-term (deal close) and $240–260 over 12 months if backlog converts and synergies materialize; use 10% stop-loss under entry. Options: buy a 12–15 month call spread to cap premium — e.g., buy Jan 2026 GTLS $200 / $260 call spread sized to target 2–3% portfolio risk. Pair: long GTLS vs short XLI or industrial-capex laggards to hedge beta (notional hedge ~0.7) over 3–12 months.

Contrarian angles: Consensus underprices deal-execution and backlog-conversion risk; if the acquisition faces regulatory delays, the implied cash floor (~$210) could evaporate, producing 10–20% downside — this appears underappreciated given modest post-deal margin drag historically in industrial M&A. Watch for order cancellations or margin erosion over two quarters; if those appear, the trade is overbought and should be trimmed or inverted to a volatility sell strategy.

Key Decisions for Investors

• Establish a 1–3% long position in GTLS common stock, layering in on pullbacks to $180–$195; set a hard stop at 10% below weighted entry (~$162–$176) and a two-tier target: $210 (deal close) and $240–$260 (12 months).
• Buy a risk-defined Jan 2026 GTLS $200 / $260 call spread sized to risk no more than 2–3% of portfolio value (max loss = debit); this captures deal-close upside while capping premium exposure over 12–15 months.
• Implement a relative-value trade: go long GTLS and short XLI (Industrial Select Sector SPDR) notional ~0.7x to neutralize market beta; hold 3–12 months and rebalance on major headlines or if GTLS underperforms by >8% vs XLI.
• If Baker Hughes regulatory filings (CFIUS/SEC) show meaningful delay or if Chart’s next two quarters show >5% sequential margin compression or order cancellations >10% of backlog, reduce GTLS exposure to 0.5% or buy protective puts (90–120 day) to hedge a 15% downside.